MPLNET.com » News » Meetings Client Login | Email | Phone: 1.800.932.2943

Meetings

13th International Conference on Pathology and Molecular Diagnosis San Diego June 27th 2017

Workshop: Contemporary genomic studies in hematologic pathology: Utility of next generation sequencing in clinical evaluation of myeloid and lymphoid malignancies. Presented by Bevan Tandon M.D. Hematopathologist and Laboratory Director Molecular Diagnostics and Genomic Solutions.

Molecular Med Tri-Con San Francisco Mar 7 2016

Short Course 18: NEXT GENERATION SEQUENCING AS A DIAGNOSTICS PLATFORM.

Jamie L. Platt, PhD. Vice President, Genomic Solutions. Advanced sequencing technologies are highly dependent on bioinformatics tools and appropriate interpretation. In addition to applying the optimized bioinformatic algorithms with specific, validated thresholds, transforming the data into clinically useful information requires appropriate annotation. The application typically dictates the knowledge base of choice as well as the clinical interpretation. Selecting or building the appropriate bioinformatics, annotation solutions and clinical interpretation are challenges for commercial clinical labs that will be discussed within the context of Genomics, Genetics, and RNA-Seq.

Tues March 8th 5:00pm. Discussion Group on NGS Assay Development and Validation led by Jamie L. Platt, PhD. Vice President, Genomic Solutions. Jamie will discuss NGS clinical test requirements – panels vs exomes/genomes; Development and validation of germline clinical NGS tests; Development and validation of somatic clinical NGS tests.

11th Annual Biomarkers Congress Manchester UK 26 Feb 2016

Clinical Diagnostics Development, NGS and Genomic Markers. Chairperson for stream Jamie Platt, PhD. Vice President Genomic Solutions.

Association for Molecular Pathology (AMP) Annual Meeting Austin Nov 5 2015

Beyond Technology: Bridging Genomics Gaps to Drive Paradigm Shifts in Clinical Research and Reference Laboratories. Presented by Jamie Platt, Ph.D. Vice President Genomic Solutions. Register for event with ThermoFIsher

33rd Annual G2 Lab Institute Washington Oct 15th 2015

Clinical Trial Services in the Molecular Diagnostics Laboratory: A Blended Business Model for Revenue Diversification. Presented by Nicholas T. Potter, PhD. FACMG, Executive Vice President of Clinical Affairs.  Molecular testing has been the most rapidly growing segment of the laboratory industry for nearly a decade, yet achieving profitability for these high-cost, high-value tests remains a challenge. Learn how your laboratory can make the most of molecular diagnostics and the evolving technologies of genomic medicine through an in-depth look at a partnership model pioneered by Molecular Pathology Laboratory Network. This case study will discuss the opportunities for laboratories to take on clinical trial work and the role of this contract work in diversifying revenue and providing financial stability

2nd Next Generation Sequencing & Bioinformatics Berlin Oct 5 2015

Bridging the Gaps in Precision Medicine through NGS in Pharma and Clinical Diagnostics. Presented by Jamie Platt, PhD. Vice President Genomic Solutions.

illumina Webinar Series Sep 23rd 2015

Advancing Pathology and Cancer Research with NGS. Presented by Jamie Platt, PhD. Vice President Genomic Solutions.

SELECTBIO Point of Care Diagnostics and Global Health World Congress 2015

San Diego Sep 18th 2015
 

Diaceutics Personalized Medicine Convergence Meeting

Philadelphia Sep 15th 2015

Thermofisher Ion Torrent Applications and Innovations Tour 2015

University of Tennessee Health Science Center Memphis TN. Sep 10th. Targeted Gene Panels for Oncology Research. Presented by Jamie Platt, PhD. Vice President Genomic Solutions.

Atlanta GA. Sep 17th. Targeted Gene Panels for Oncology Research. Presented by Jamie Platt, PhD.

6th Annual World CDx Boston Summit Sep 8th 2015

 

Next Generation Dx Summit.  Aug 2015

AUG 17th. 2:00pm. Short Course (SC7). NGS AS A DIAGNOSTICS PLATFORM. Part One: How Multi-Gene Panel and Exome Testing are Becoming New Diagnostic Standards for Inherited Disorders. Presented by Jamie Platt, PhD. Vice President Genomic Solutions.

AUG 20th.7:30 am. Problem-Solving Breakout Discussions. NGS Annotation and Interpretation: Practical Approaches. Presented by Jamie Platt, Ph.D. Vice President Genomic Solutions.

AUG 20th 2:00pm. NGS ANNOTATION IN GENOMICS, GENETICS, AND RNA-SEQ. The NGS Annotation Landscape for Genomics, Genetics, and RNA-Seq: Current Challenges for Commercial Clinical Labs. Presented by Jamie Platt, PhD. Vice President Genomic Solutions.

RainDance User Group Meeting in conjunction with the Festival of Genomics June 22 2015

New User Experience: Validating the RainDrop and ThunderBolts Systems. Presented by Jamie Platt, PhD. Vice President Genomic Solutions.

San Diego Medical Genomics Summit June 7th 2015

From LDTs to NGS IVD Systems, A Customer’s Perspective. Presented by Jamie Platt, PhD. Vice President Genomic Solutions.

Biomarkers and Diagnostics World Congress May 7th 2015

Opportunities and Challenges for NGS-Based Clinical Trials. Jamie L. Platt, PhD. Vice President, Genomic Solutions, Geneuity (an MPLN company)

Molecular Dx. Europe April 13th 2015

Global Innovation and Marketing in NGS. Panelist. Jamie L. Platt, PhD. Vice President, Genomic Solution

Molecular Med Tri-Con 2015. Feb 11th.

Biospecimen Science and Sample Prep. NGS-Based Clinical Assays: Building Castles in the Air. Jamie L. Platt, PhD.

FDA-Approved Versus LDT-Based NGS Systems: Preanalytical Issues and Validation. Jamie L. Platt, PhD.

PANEL DISCUSSION: Comparing Major NGS Instruments: Technical Differences, Application Preferences

3rd Annual Clinical Genome Conference. 2014

Clinical Next-Generation Sequencing in the CLIA Environment: Mythos and Logos in Today’s Molecular Labs . Jamie L. Platt, PhD. CGMBS, MB(ASCP), Vice President, Genomic Solutions, Molecular Pathology Laboratory Network, Inc.